OneSource Specialty Pharma Ltd

544292

Summary

Fair Value Assessment
Undervalued (4% Discount)
Fair ValueQ1,809.99UncertaintyVery High
Close Price1,719.65Mar 26, 2025
Market Closed
1,719.65
Price Up by 1.15 | 0.07 %
Previous Close
1,719.65
Day Range
1,637.60 – 1,741.45
Year Range
1,163.05 – 1,754.00
Bid / Ask
Market Cap
196.8 Bil
Volume / Average
9.1 k / 30.8 k
Beta
Shares Outstanding
114.44 Mil
Primary Exchange
Bombay Stock Exchange

Business Description
OneSource Specialty Pharma Ltd is engaged in the research, development, manufacture, and commercialization of biological drug products in different injectable formats. The company also offers end-to-end CDMO services across all phases of pre-clinical and clinical development and commercial supply of biologics. The company’s reportable segments are Unit 1 - R&D and Unit 2 : CDMO-1 (Contract Development & Manufacturing Organization); and Unit 3: Multimodal Facility and CDMO-2.
Contact
Bannerghatta Road Star 1, Opp IIM Bangalore, Bangalore, KA 560076
T +91 8067840738
www.onesourcecdmo.com opens in a new tab
Sector
Healthcare
Industry
Biotechnology
Most Recent Earnings
Mar 31, 2024
Fiscal Year End
Mar 31, 2025
Employees

Key Metrics

Income Statement (in Mil, except ratios)
03/31/2024
03/2024
03/2023
03/2020
Revenue
1,719.19 1,719.19 387.14
Revenue Growth %
344.07% 344.07%
Gross Profit
1,014.10 1,014.10 183.03
Gross Profit Margin %
58.99% 58.99% 47.28%
Operating Income
-1,565.25 -1,565.25 -2,158.82
Operating Margin %
-91.05% -91.05% -557.63%
EBIT
-2,822.15 -2,822.15 -3,771.18
EBIT Margin %
-164.16% -164.16% -974.11%
EBITDA
-2,059.22 -2,059.22 -3,114.38
EBITDA Margin %
-119.78% -119.78% -804.46%
Net Income
-3,911.65 -3,911.65 -7,998.30
Net Profit Margin %
-212.71% -212.71% -1,073.63%
Basic EPS
-34.18 -34.18
Diluted EPS
-34.18 -34.18
Normalized EPS
Total Dividends per Share
Balance Sheet (in Bil, except ratios)
03/31/2024
03/2024
03/2023
Total Assets
13.09 13.09 20.09
Total Liabilities
9.13 9.13 12.23
Total Debt
5.71 5.71 8.64
Total Equity
3.96 3.96 7.85
Cash And Cash Equivalents
0.06 0.06 0.05
Working Capital
-4.54 -4.54 -6.37
Shares Outstanding (Mil)
Book Value Per Share
Total Debt To Equity
1.44 1.44 1.10
Cash Flow Statement (in Mil, except ratios)
03/31/2024
03/2024
03/2023
03/2020
Cash From Operating Activities
-1,072.11 -1,072.11 -1,627.65
Cash From Investing Activities
5,105.45 5,105.45 -678.34
Cash From Financing Activities
-3,905.44 -3,905.44 1,183.18
Capital Expenditures
637.67 637.67 439.95
Free Cash Flow
-2,701.27 -2,701.27 -3,337.51
Change in Cash
127.90 127.90 -1,122.81

Profile

There is no Key Executive Team data available.
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
No Data Available
There is no available information for this investment.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
No Data Available
There is no available information for this investment.

Ownership


© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top